Literature DB >> 16165175

Does longevity of adult Wuchereria bancrofti increase with decreasing intensity of parasite transmission? Insights from clinical observations.

Gerusa Dreyer1, David Addiss, Joaquim Norões.   

Abstract

To interrupt transmission of Wuchereria bancrofti, a parasite that causes lymphatic filariasis, mass treatment of at-risk populations with antifilarial drugs is recommended for 4-6 years, the minimum estimated adult worm lifespan. Factors associated with adult worm longevity are unknown. In Recife, Brazil, we conducted a retrospective cohort study of 57 men whose adult W. bancrofti were not sensitive to diethylcarbamazine and who were followed with semi-annual physical examinations (to detect intrascrotal nodules, indicative of adult worm death) and ultrasound examinations (to detect the 'filaria dance sign' (FDS), indicative of living adult worms). After 5 years, the FDS remained detectable in 10 (24.4%) of 41 adult worm nests in 25 men from areas of high filariasis transmission intensity and in 30 (90.9%) of 33 nests in 32 men from areas of low transmission (P<0.001). New nodules and adult worm nests were detected only in men from high-transmission areas. Of 30 men who were microfilaria-positive initially and whose FDS remained detectable after 5 years of follow-up, 19 (63.3%) remained microfilaria-positive in 5 ml blood (mean density, 0.4 per ml). In conclusion, survival of adult W. bancrofti is inversely associated with transmission intensity. These findings have implications for filariasis elimination and research.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16165175     DOI: 10.1016/j.trstmh.2005.05.006

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  10 in total

1.  Effect of single to triple dose DEC on microfilaremics up to 5 years.

Authors:  Goutam Chandra; Manas Paramanik
Journal:  Parasitol Res       Date:  2008-08-05       Impact factor: 2.289

2.  Semi-quantitative scoring of an immunochromatographic test for circulating filarial antigen.

Authors:  Cédric B Chesnais; François Missamou; Sébastien D S Pion; Jean Bopda; Frédéric Louya; Andrew C Majewski; Gary J Weil; Michel Boussinesq
Journal:  Am J Trop Med Hyg       Date:  2013-09-09       Impact factor: 2.345

3.  Elimination of diurnally sub-periodic Wuchereria bancrofti in Andaman and Nicobar Islands, India, using mass DEC-fortified salt as a supplementary intervention to MDA.

Authors:  A N Shriram; Addepalli Premkumar; K Krishnamoorthy; Amitabha De; S K Paul; S Subramanian; P Vijayachari; P Jambulingam
Journal:  Parasitol Res       Date:  2020-03-26       Impact factor: 2.289

4.  The impact of a filariasis control program on Lihir Island, Papua New Guinea.

Authors:  Oriol Mitjà; Raymond Paru; Russell Hays; Lysaght Griffin; Nedley Laban; Mellie Samson; Quique Bassat
Journal:  PLoS Negl Trop Dis       Date:  2011-08-23

5.  Validation of ultrasound bioimaging to predict worm burden and treatment efficacy in preclinical filariasis drug screening models.

Authors:  Amy E Marriott; Hanna Sjoberg; Hayley Tyrer; Joanne Gamble; Emma Murphy; John Archer; Andrew Steven; Mark J Taylor; Joseph D Turner
Journal:  Sci Rep       Date:  2018-04-12       Impact factor: 4.379

6.  Efficacy and Safety of a Single Dose of Ivermectin, Diethylcarbamazine, and Albendazole for Treatment of Lymphatic Filariasis in Côte d'Ivoire: An Open-label Randomized Controlled Trial.

Authors:  Catherine M Bjerum; Allassane F Ouattara; Méité Aboulaye; Olivier Kouadio; Vanga K Marius; Britt J Andersen; Gary J Weil; Benjamin G Koudou; Christopher L King
Journal:  Clin Infect Dis       Date:  2020-10-23       Impact factor: 9.079

7.  Diethylcarbamazine and non-diethylcarbamazine related bancroftian granuloma: an immunohistochemical study of eosinophil toxic proteins.

Authors:  Jose Figueredo-Silva; Carmelita Cavalcanti; Luciano Tavares Montenegro; Joaquim Norões; Gerusa Dreyer
Journal:  Int J Biomed Sci       Date:  2010-06

8.  Nature limits filarial transmission.

Authors:  Goutam Chandra
Journal:  Parasit Vectors       Date:  2008-05-23       Impact factor: 3.876

9.  Defining a prevalence level to describe the elimination of Lymphatic Filariasis (LF) transmission and designing monitoring & evaluating (M&E) programmes post the cessation of mass drug administration (MDA).

Authors:  Benjamin S Collyer; Michael A Irvine; T Deidre Hollingsworth; Mark Bradley; Roy M Anderson
Journal:  PLoS Negl Trop Dis       Date:  2020-10-12

Review 10.  Recombinant antigens used as diagnostic tools for lymphatic filariasis.

Authors:  André Filipe Pastor; Maressa Rhuama Silva; Wagner José Tenório Dos Santos; Tamisa Rego; Eduardo Brandão; Osvaldo Pompilio de-Melo-Neto; Abraham Rocha
Journal:  Parasit Vectors       Date:  2021-09-15       Impact factor: 3.876

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.